Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB2R selective benzimidazoles reveal unexpected intrinsic properties
| Autor: | Daniela Pemp, Michael Decker, Fouad H. Darras, Jörg Heilmann, Xinyu Chen, Martin Nimczick |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Agonist
Cannabinoid receptor medicine.drug_class Chemistry Stereochemistry medicine.medical_treatment Organic Chemistry Clinical Biochemistry Pharmaceutical Science Biochemistry Endocannabinoid system Drug Discovery Cannabinoid receptor type 2 medicine Molecular Medicine Inverse agonist Cannabinoid Receptor Molecular Biology G protein-coupled receptor |
| Zdroj: | Bioorganic & Medicinal Chemistry. 22:3938-3946 |
| ISSN: | 0968-0896 |
| DOI: | 10.1016/j.bmc.2014.06.008 |
| Popis: | The design of bivalent ligands targeting G protein-coupled receptors (GPCRs) often leads to the development of new, highly selective and potent compounds. To date, no bivalent ligands for the human cannabinoid receptor type 2 (hCB2R) of the endocannabinoid system (ECS) are described. Therefore, two sets of homobivalent ligands containing as parent structure the hCB2R selective agonist 13a and coupled at different attachment positions were synthesized. Changes of the parent structure at these positions have a crucial effect on the potency and efficacy of the ligands. However, we discovered that bivalency has an influence on the effect at both cannabinoid receptors. Moreover, we found out that the spacer length and the attachment position altered the efficacy of the bivalent ligands at the receptors by turning agonists into antagonists and inverse agonists. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect